Inhaled Pulmonary Vasodilators in Cardiac Surgery Patients: Correct Answer Is "NO"
- PMID: 28731972
- PMCID: PMC5644498
- DOI: 10.1213/ANE.0000000000002239
Inhaled Pulmonary Vasodilators in Cardiac Surgery Patients: Correct Answer Is "NO"
Conflict of interest statement
Comment on
-
Aerosolized Vasodilators for the Treatment of Pulmonary Hypertension in Cardiac Surgical Patients: A Systematic Review and Meta-analysis.Anesth Analg. 2017 Aug;125(2):393-402. doi: 10.1213/ANE.0000000000002138. Anesth Analg. 2017. PMID: 28598920
References
-
- Vlahakes GJ. Right ventricular failure after cardiac surgery. Cardiology clinics. 2012;30:283–289. - PubMed
-
- Ichinose F, Roberts JD, Jr, Zapol WM. Inhaled nitric oxide: A selective pulmonary vasodilator: Current uses and therapeutic potential. Circulation. 2004;109:3106–3111. - PubMed
-
- Elmi-Sarabi M, Deschamps A, Delisle S, Ased H, Haddad F, Lamarche Y, Perrault LP, Lambert J, Turgeon AF, Denault AY. Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: a systematic review and meta-analysis. Anesthesia Analgesia. 2017 - PubMed
-
- Lowson SM. Alternatives to nitric oxide. Br Med Bull. 2004;70:119–131. - PubMed
-
- Olschewski H, Walmrath D, Schermuly R, Ghofrani HA, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Annals of Internal Medicine. 1996;124:820–824. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
